Edinburgh BioQuarter

It's Day! 🌍

At Edinburgh BioQuarter, we’re working towards a more sustainable future - from promoting active travel to creating green, connected spaces where our community can thrive.

As we continue to grow into Edinburgh’s Health Innovation District, sustainability is playing an important role in shaping how people live, work, travel and connect across the campus and beyond.

Here are a few ways BioQuarter is helping support a greener future:

🌿 Encouraging active travel through walking, wheeling and cycling routes that better connect the campus to neighbouring communities and green spaces.

♻️ Delivering community engagement activities that explore sustainability and environmental themes through science, creativity and learning.

🧪 Reusing and redistributing resources, including unused laboratory equipment for local schools, to help reduce waste and support STEM education.

💬 We’d love to hear from you - what small changes are you making to live or work more sustainably? Share your ideas in the comments!

📢 Have your say on the future of Edinburgh BioQuarter!

Exciting plans are being developed for BioQuarter, as Scottish Enterprise brings forward proposals for a new mixed-use masterplan - and your input is really important.

This is a chance for the community to help shape a space where innovation, homes, green spaces and everyday life come together.

🗣️ Come along to the next public consultation event on Tuesday, 9 June 2026, at Goodtrees Neighbourhood Centre to:
• Meet the team
• Take a look at the ideas
• Share your thoughts and feedback

Whether you live, work or spend time in the area, your voice matters and can help shape what BioQuarter becomes in the future.

👇 Visit the website for more details and get involved!
https://ebqconsultation.com/

🧬 Last week, Institute for Regeneration and Repair spinout, Trogenix, took a major step towards eradicating one of the most aggressive forms of brain cancer.

The findings, published in Nature Magazine, highlight complete tumour eradication in 83% of cases in a pre-clinical model of glioblastoma. Through a new gene therapy approach, the treatment not only destroyed tumours but also activated the immune system to prevent them from returning, all without damaging healthy brain tissue. 🧠

With Trogenix now a step closer to clinical trials, this offers patients and families facing the devastating disease a real hope for more effective treatments.

Speaking on next steps, Chief Scientific Officer of Trogenix, Professor Steve Pollard, said: "We are committed to moving these findings as quickly and safely as possible to patients and are optimistic that this can provide a new approach to tackling solid tumours."

The end goal of all the work done at Edinburgh BioQuarter is to have a real-world impact and help those facing some of the toughest health challenges. This research is a stellar example of the innovation and breakthroughs our community of life-science experts can achieve when they collaborate and bring their vast experience and knowledge together.

Discover more about the ground-breaking research here: https://go.nature.com/4tGG1HS